Stage III Follow-Up
After treatment, all patients with Stage III melanoma should receive a physical examination, including a skin examination, using the following schedule. Regular chest x-rays, CT scans of the trunk and pelvis, and brain MRI may also be recommended.
|Type of Follow-up||Description|
Annually by healthcare provider
Years 1-2: every 3-6 months
Possibly every 3-12 months to check for recurrence
Possibly each year
All patients with Stage III melanoma should have a skin examination once a year for life. Patients should have a physical examination every 3-6 months for years 1-2, every 3-12 months for years 3-5, and then once a year as needed.
Imaging tests are recommended if specific signs of cancer appear. You may also receive imaging tests every 3-12 months to check for cancer recurrence that isn’t causing symptoms. Possible tests for screening include a chest x-ray, CT scan, PET/CT scan, and brain MRI. These tests may be done for up to 5 years after treatment has ended. Imaging tests are not recommended after 5 years if there has been no recurrence and no symptoms.
With treatment, Stage III melanoma is considered intermediate- to high-risk for local recurrence or distant metastasis.
Therefore, early detection of melanoma through skin self-examination and medical examination continues to be of utmost importance.
Large-scale studies have shown the following probabilities of disease-free survival. Keep in mind that the statistics shown for survival are averages; everyone’s cancer and survival rate is based on many factors and determined on an individual basis.
|5 years after treatment 1||10 years after treatment1|
Stage IIIA: 93%
Stage IIIA: 88%
Stage IIIB: 83%
Stage IIIB: 77%
Stage IIIC: 69%
Stage IIIC: 60%
Stage IIID: 32%
Stage IIID: 24%
Living With Melanoma: Free Symposiums
Join leading melanoma experts in an educational symposium for patients and the people who support them.Sign up Today
1. Gershenwald JE, Final Version of 2017 AJCC Melanoma Staging and Classification.